#145 Biobeat, an Israeli remote patient monitoring (RPM) startup, is looking for Dutch hospitals and health-related organizations to setup pilot and demonstration projects
- Industry Life sciences and health
- Online since 2021-10-05
Biobeat, an Israeli startup, is interested in developing business oriented collaborations (i.e., implementations, pilots, sales) with Dutch entities active in remote patient monitoring (RPM), such as hospitals, insurance companies, distributors, telehealth providers and pharmaceutical companies.
Biobeat is a med-tech company with unique health-AI abilities in the patient monitoring space. The company’s remote patient monitoring (RPM) health-AI platform includes a disposable short-term chest-monitor and a long-term wrist-monitor, both of which utilize a photoplethysmography-based (PPG) sensor to continuously provide accurate patient readings of 13 health parameters, including cuffless blood pressure, pulse rate, respiratory rate, blood oxygen saturation, temperature, stroke volume, cardiac output, one lead ECG (only chest-monitor) and more. Aggregated patient health data is viewed by medical staff via Biobeat’s secure HIPPA and GDPR compliant cloud-based patient management platform, which utilizes an automated real-time early warning score (EWS) system that incorporates advanced AI-based algorithms to provide alerts on patient health status and potential deterioration. Biobeat’s wearable devices are the first devices to be FDA-Cleared for cuffless non-invasive blood pressure monitoring and are also CE Mark certified.
Contact: Tamir Raveh, Sales Development Representative, mobile: +972 50 6428895, email: [email protected]
Go to website